Akari Therapeutics (AKTX) EBT Growth (3y) (2019 - 2026)

Akari Therapeutics (AKTX) EBT Growth (3y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 84.25%
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 32.96%
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 28.95%
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -49.71%
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 20.92%
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 12.01%
9 Abivax 90.15 Bn 90.15 Bn - -
10 Regeneron Pharmaceuticals 63.59 Bn 54.83 Bn 3.31 Bn -1.05%

Historic Data

Download Data
DateValue
Mar 31, 2026 -49.71%
Dec 31, 2023 9.64%
Sep 30, 2023 -117.91%
Jun 30, 2023 8.11%
Mar 31, 2023 2.51%
Mar 31, 2019 26.09%